Renowned clinician and cancer researcher Dr. Hagop Kantarjian is stepping down as head of MD Anderson's leukemia department ...

Dr. Breelyn Wilky explains how vague symptoms and testing challenges delay GIST diagnoses; however, molecular testing can ...

Many patients value conversations with their rheumatologists and oncologists more than just reading information from a website.

A new study from University of Michigan Rogel Cancer Center researchers identifies a cellular signature that explains why about one-third of prostate cancers respond especially poorly to treatment.

Mary Beckerle is stepping down from her long tenure as CEO of Huntsman Cancer Institute at the University of Utah. Beckerle ...

The value of a recent biochemical discovery can be seen in the case of an 8-year-old boy who was playing typical sports in ...

ALLO-316 shows promising results in advanced renal cell carcinoma, with a 25% response rate and rapid treatment turnaround, ...

A new study by University of Michigan Rogel Cancer Center researchers identifies a cellular signature that explains why about ...

In a clinical practice guideline issued by the American Society for Radiation Oncology and published online June 25 in ...

STAMPEDE otherwise follows a line of randomized trials (e.g., MAST, TAXOMET, IMPROVE) that have failed to prove cancer ...

The funds will be used to support pet owners who cannot afford chemotherapy, surgery and other life-saving treatment ...

Cooper University Hospital Cape Regional is now an approved radiation oncology site of MD Anderson Cancer Center at Cooper.